S
Salehi Retina Institute Inc. | Huntington Beach, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
UBX1325
KHK4951
Iptacopan
Foselutoclax
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
4 of 6 total trials
The purpose of this study is to assess the effect of Iptacopan to prevent conversion of early or intermediate age-related macular degeneration (AMD)...
Enrolling
Age-Related Macular Degeneration
Drug: Placebo
Drug: Iptacopan (LNP023)
The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Ed...
Enrolling
Edema
Diabetic Macular Edema
Drug: foselutoclax
Drug: Aflibercept
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.
Enrolling
Diabetic Macular Edema (DME)
Drug: KHK4951
Drug: Aflibercept Injection
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.
Enrolling
Neovascular Age-Related Macular Degeneration (nAMD)
Drug: Aflibercept Injection
Drug: KHK4951
Trial sponsors
U
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems